loadpatents
name:-0.01338005065918
name:-0.009861946105957
name:-0.00049901008605957
Rudolph; M. Jonathan Patent Filings

Rudolph; M. Jonathan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rudolph; M. Jonathan.The latest application filed is for "method of inhibiting c-kit kinase".

Company Profile
0.10.9
  • Rudolph; M. Jonathan - Doylestown PA
  • Rudolph; M. Jonathan - Exton PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method of inhibiting C-KIT kinase
Grant 9,526,731 - Illig , et al. December 27, 2
2016-12-27
Method Of Inhibiting C-kit Kinase
App 20150094520 - ILLIG; Carl R. ;   et al.
2015-04-02
Method of inhibiting C-KIT kinase
Grant 8,933,091 - Illig , et al. January 13, 2
2015-01-13
Method of inhibiting C-KIT kinase
Grant 8,697,716 - Illig , et al. April 15, 2
2014-04-15
Method Of Inhibiting C-kit Kinase
App 20140005225 - Illig; Carl R. ;   et al.
2014-01-02
Method of inhibiting FLT3 kinase
Grant 7,795,279 - Ballentine , et al. September 14, 2
2010-09-14
Inhibitors of c-fms kinase
Grant 7,662,837 - Illig , et al. February 16, 2
2010-02-16
Inhibitors of c-fms kinase
Grant 7,645,755 - Illig , et al. January 12, 2
2010-01-12
Method Of Inhibiting C-kit Kinase
App 20080051402 - Illig; Carl R. ;   et al.
2008-02-28
Method Of Inhibiting Flt3 Kinase
App 20070149572 - Ballentine; Shelley K. ;   et al.
2007-06-28
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
Grant 7,109,354 - Subasinghe , et al. September 19, 2
2006-09-19
Inhibitors of c-fms kinase
App 20060189623 - Illig; Carl R. ;   et al.
2006-08-24
Inhibitors of c-fms kinase
App 20060100201 - Illig; Carl R. ;   et al.
2006-05-11
Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
App 20040009995 - Subasinghe, Nalin ;   et al.
2004-01-15
Compounds and compositions for treating C1s-mediated diseases and conditions
Grant 6,515,002 - Illig , et al. February 4, 2
2003-02-04
Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors
Grant 6,403,633 - Illig , et al. June 11, 2
2002-06-11
Compounds and compositons for treating C1s-mediated diseases and conditions
App 20020037915 - Illig, Carl R. ;   et al.
2002-03-28
Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors
App 20010031781 - Illig, Carl R. ;   et al.
2001-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed